IJRPC 2013, 3(2) Nagamallika et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

Similar documents
Research Article Simultaneous Estimation of DL-Methionine and Pyridoxine Hydrochloride in Tablet Dosage Form by RP-HPLC

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

International Journal of Chemical and Analytical Science ISSN: Research Article

World Journal of Pharmaceutical Research

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

Stability indicating RP-HPLC method development and validation of Etizolam and Propranolol hydrochloride in pharmaceutical dosage form

Stress Degradation Studies And Validation Method For Quantification Of Aprepitent In Formulations By Using RP-HPLC

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

International Journal of Pharma and Bio Sciences

SUMMARY, CONCLUSION & RECOMMENDATIONS

Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method

Journal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article

Development and Validation of Stability Indicating HPLC method for Determination of Eperisone HCL in Bulk and in Formulation

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

Pelagia Research Library

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

Sanjog Ramdharane 1, Dr. Vinay Gaitonde 2

Journal of Chemical and Pharmaceutical Research

Development and validation of related substances method for Varenicline and its impurities

Int. J. Pharm. Sci. Rev. Res., 30(1), January February 2015; Article No. 32, Pages:

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

Abstract. G. D. Patil 1, P. G. Yeole 1, Manisha Puranik 1 and S. J. Wadher 1 *

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

vii LIST OF TABLES TABLE NO DESCRIPTION PAGE 1.1 System Suitability Parameters and Recommendations Acidic and Alkaline Hydrolysis 15

Dhull Rohit, Kumar Sanjay, Jalwal Pawan Department of Chemistry, OPJS Churu, Rajasthan, India

(ACE) inhibitor class that is primarily used in cardiovascular. conditions. Lisinopril was introduced into therapy in the early

Isocratic Reversed Phase Liquid Chromatographic Method Validation for the Determination of Cilostazol in Pure and Formulations

Rao and Gowrisankar: Stability-indicating RP-HPLC Method for Pseudoephedrine, Ambroxol and Desloratadine

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

A stability indicating RP-HPLC method for simultaneous estimation of darunavir and cobicistat in bulk and tablet dosage form

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

S. G. Talele, D. V. Derle. Department of Pharmaceutics, N.D.M.V.P. College of Pharmacy, Nashik, Maharashtra, India

A Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Meclizine Hydrochloride in Tablet Dosage Form

Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms

ISSN (Print)


36 J App Pharm Vol. 6; Issue 1: 36-42; January, 2014 Rao et al., 2014

HPTLC Determination of Atomoxetine Hydrochloride from its Bulk Drug and Pharmaceutical Preparations

New RP-HPLC Method for the Determination of Fludarabine in Pharmaceutical Dosage Forms

Pelagia Research Library

ESTIMATION OF OXOLAMINE PHOSPHATE INDICATING HPLC METHOD: METHOD DEVELOPMENT AND VALIDATION

Development and validation of RP-HPLC method for simultaneous estimation of gliclazide and metformin in pure and tablet dosage form

Development of a Validated RP-HPLC Method for the Analysis of Citicoline Sodium in Pharmaceutical Dosage Form using Internal Standard Method

Journal of Chemical and Pharmaceutical Research

VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DEXAMETHASONE AND GRANISETRON IN COMBINED DOSAGE FORMS

Available Online through (or) IJPBS Volume 2 Issue 4 OCT-DEC Research Article Pharmaceutical Sciences

Available online Research Article

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

A Validated Stability Indicating RP-HPLC Method for Simultaneous Estimation of Valsartan and Clinidipine Combined Tablet dosage forms

CHAPTER-5. Sumatriptan Succinate

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

RP-HPLC Method for the Simultaneous Estimation of Sitagliptin Phosphate and Metformin Hydrochloride in Combined Tablet Dosage Forms

Development and Validation of Stability Indicating HPTLC Method for Estimation of Seratrodast

Development and Validation of a Simultaneous HPLC Method for Quantification of Amlodipine Besylate and Metoprolol Tartrate in Tablets

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Scholars Research Library

Stability Indicating Method Development and Validation for the Estimation of Rotigotine by RP-HPLC in Bulk and Pharmaceutical Dosage Form

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

Ankit et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), Available online at RESEARCH ARTICLE

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

Simultaneous Determination of Halobetasol and Salicylic Acid Related Substances by Reversed Phase High Performance Liquid Chromatographic Method

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

Scholars Research Library. Der Pharmacia Lettre, 2016, 8 (6): (

Int. J. Pharm. Sci. Rev. Res., 32(1), May June 2015; Article No. 33, Pages:

Development and Validation of RP-HPLC Method for the Estimation of Gemigliptin

International Journal of Applied Pharmaceutical Sciences and Research

Validated UV Spectrophotometric Method Development And Stability Studies Of Acamprosate Calcium In Bulk And Tablet Dosage Form

CHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG

Tentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40

Available online at Scholars Research Library

Available online at Scholars Research Library

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

Simple and stability indicating RP-HPLC assay method development and validation lisinopril dihydrate by RP-HPLC in bulk and dosage form

Development and Validation of Stability Indicating RP- HPLC Method for Simultaneous Estimation of Beclomethasone Dipropionate and Clotrimazole

Method Development and Validation for the Estimation of Saroglitazar in Bulk and Pharmaceutical Dosage Form by RP-HPLC

International Journal of Drug Research and Technology

Available online Research Article

J Pharm Sci Bioscientific Res (4): ISSN NO

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

Volume 6, Issue 1, January February 2011; Article-021

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

SIMULTANEOUS ESTIMATION OF LEVOCETIRIZINE DIHYDROCHLORIDE AND MONTELUKAST SODIUM BY RP-HPLC METHOD

DEVELOPMENT AND VALIDATION OF NEW HPLC METHOD FOR THE ESTIMATION OF PALIPERIDONE IN PHARMACEUTICAL DOSAGE FORMS

ANALYTICAL TECHNIQUES FOR THE QUALITY OF ANTI- AIDS DRUGS

Volume 2 (6), 2014, Page CODEN (USA)-IJPRUR, e-issn: International Journal of Pharma Research and Health Sciences

A Reverse Phase HPLC Method Development and Validation for the Determination of Paliperidone in Pure and Dosage Forms

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

Asian Journal of Chemistry Vol. 21, No. 1 (2009),

Estimation of zolmitriptan by a new RP-HPLC method

Simultaneous estimation of Rabeprazole and Mosapride by RP-HPLC method in tablet dosage form

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF BACLOFEN IN BULK AND PHARMACEUTICAL DOSAGE FORMS

Development and Validation of a Stability Indicating HPLC Method for Determination of Erlotinib Hydrochloride in Bulk

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ETORICOXIB AND THIOCOLCHICOSIDE IN PHARMACEUTICAL DOSAGE FORMS

DEVELOPMENT OF RP-HPLC METHOD FOR ESTIMATION OF DROTAVERINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATIONS

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

Estimation of Emtricitabine in Tablet Dosage Form by RP-HPLC

Transcription:

INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article A VALIDATED STABILITY INDICATING RP-UPLC METHOD FOR SIMULTANEOUS DETERMINATION OF WATER SOLUBLE VITAMINS, CAFFEINE AND PRESERVATIVES IN PHARMACEUTICAL FORMULATIONS G. Nagamallika 1* and M. Aruna Devi 2 1 QIS College of Pharmacy, Ongole, Andhra Pradesh, India. 2 CVM College of Pharmacy, Karimnagar. Andhra Pradesh, India. ABSTRACT A novel, sensitive and selective stability-indicating gradient reverse phase ultra performance liquid chromatographic method was developed and validated for the quantitative determination of thiamine hydrochloride, riboflavin-5 -phosphate sodium, pyridoxine hydrochloride, Nicotinamide, D (+)-Panthenol, caffeine and two preservatives (Methylparaben and proylparaban) in multivitamin syrup preparation. The chromatographic separation was achieved on HSS T3 50mm 2.1mm,1.7µm column by using mobile phase containing a gradient mixture of solvent A (0.1% Trifluoro acetic acid in water) and solvent B(50:50 v/v mixture of Acetonitrile and methanol at flow rate of 1.0 ml min -1. Column temperature was maintained at 48 C and detection was carried out at 200, 254 and 290 nm. The described method shows excellent linearity and the correlation coefficient for thiamine hydrochloride, riboflavin-5 -phosphate sodium, pyridoxine hydrochloride, Nicotinamide, D (+)-Panthenol, caffeine, Methylparaben and proylparaban was more than 0.99. To establish stability-indicating capability of the method, drug product was subjected to the stress conditions of acid, base, oxidative, hydrolytic, thermal and photolytic degradation. The degradation products were well resolved from thiamine hydrochloride, riboflavin-5 -phosphate sodium, pyridoxine hydrochloride, Nicotinamide, D (+)- Panthenol, caffeine, Methylparaben and propylparaban. The developed method was validated as per ICH guidelines with respect to specificity, linearity, accuracy, precision and robustness. Keywords: Water-soluble vitamins, Preservatives, UPLC stability-indicating, Multivitamin syrup. 1.0 INTRODUCTION Vitamins are biologically active compounds which act as controlling agents for an organism s normal health and growth. Vitamins are vital to human development and long-term health; therefore, infants are usually prescribed a vitamin supplement to ensure they receive the recommended daily allowance of each vitamin. Children under one year of age are usually given this supplement in liquid form. Vitamins are a chemically diverse set of compounds varying in size, structure, and other properties. They are generally classified by their water solubility, with the classifications of water-soluble and fat-soluble. A thorough literature survey has revealed many spectrophotometric and HPLC methods for the estimation of vitamin(s) in biological fluids and pharmaceutical formulations 1-6. To the best of our knowledge, there is no stability-indicating UPLC method reported for the simultaneous estimation of water soluble vitamins, caffeine and preservatives in syrup formulation. Therefore, attempts were made in this study to develop a fast, sensitive, selective and stability-indicating reverse phase ultraperformance liquid chromatography (UPLC) method for the simultaneous determination of 456

water soluble vitamins, caffeine and preservatives in syrup formulation. The proposed method is able to separate all the vitamins, caffeine and preservatives with each other and from their impurities, degradation products and placebo components. The developed UPLC method was validated with respect to specificity, linearity, limit of detection and quantification, precision, accuracy and robustness. 2.0 MATERIALS AND METHODS All the reagents were of analytical-reagent or LC grade unless stated otherwise. Milli-Qwater was used throughout the experiment. Working standards of Water soluble Vitamins (Pyridoxine Hydrochloride, Nicotinamide, D- Panthenol, Thiamine Hydrochloride, Riboflavin 5-Phosphate), Caffeine, Methyl hydroxy benzoate and Propyl hydroxy benzoate, Multivitamin syrup preparation, were obtained from M/S ADCOCK INGRAM, RD&I, Sabax Road, Aero ton, Johannesburg, 2013, South Africa. Sodium hydroxide, Hydrochloric acid, Hydrogen peroxide, Trifluoro acetic acid, acetonitrile and methanol were procured from Merck, Mumbai. 2.1 Apparatus The UPLC system consisted of high pressure pump, Photo diode array detector and 10 μl capacity injector loops. The column used was HSS T3 50mm 2.1mm, 1.7µm column. The output signal was monitored and processed using Empower software. 2.2 Chromatographic conditions HSS T3, 50 2.1 mm, 1.7μm column was used for separation. Chromatographic separation was achieved using timed gradient. The mobile phase consisting of A: buffer (0.1% Trifluoro acetic acid in water) and B: a mixture of 50% acetonitrile and 50% methanol with a timed gradient programme was used. The gradient condition of the mobile phase was: 0 min 0% solvent B, 0.1 min 2% solvent B, 1.6 min 12% solvent B, 2.8 min 12% solvent B, 3 min 55% solvent B, 3.8 min 2% solvent B and 4 min 2% solvent B with further 2 min for system equilibration. The flow rate of the mobile phase was 1.0 ml/min with detection at 190-400 nm. The column temperature was kept at 48 o C and the injection volume was 10 μl. 2.3 solution preparation 2.3.1 Standard stock solution 2.7mg/mL of Caffeine; 0.11mg/mL of Riboflavin-5 Phosphate; 0.09mg/mL of Pyridoxine Hydrochloride; 0.42mg/mL of Nicotinamide; 0.16mg/mL of Thiamine HCl; 0.11mg/mL of D-Panthenol and 0.27mg/mL of Methylparaben; 0.03mg/mL of Propylparaben in water. 2.3.2 Sample solution 2.7mg/mL of Caffeine; 0.11mg/mL of Riboflavin-5 Phosphate; 0.09mg/mL of Pyridoxine Hydrochloride; 0.42mg/mL of Nicotinamide; 0.16mg/mL of Thiamine HCl; 0.11mg/mL of D-Panthenol and 0.27mg/mL of Methylparaben; 0.03mg/mL of Propylparaben in water from Multivitamin syrup preparation. 2.4 stress degradation study To determine whether the analytical method was stability indicating, standard solution was stressed under various conditions includes photolytic degradation (Exposed to 1.2 billion Lux.), acid hydrolysis (1N Hydrochloric acid at 50 0 C for 3 days), base hydrolysis (1N sodium hydroxide at 50 0 C for 3 days), thermal degradation (at 60 0 C for 3 days) and Oxidative degradation (3% Hydrogen peroxide at 50 0 C for 3 days). 2.5 method validation The method was validated according to International Conference on Harmonisation (ICH) guidelines for validation of analytical procedures. The validated parameters were system suitability, specificity, range and linearity, limit of detection (LOD), limit of quantification (LOQ), accuracy, precision, ruggedness and robustness 7. 3.0 RESULT AND DISCUSSION Different chromatographic conditions were tested to develop the stability-indicating LC method. The mobile phase was optimized through the evaluation of different buffers and organic solvents. The use of 0.1% Trifluoro acetic acid and acetonitrile in gradient mode resulted in better peak symmetry and good resolution and short run time. Due to the different absorption max of analytes, the elution was monitored at 200nm; 254nm and 290nm. These all polar analytes retained with in 4.0min runtime and maximum separation using high strength silica with reduced particle size Stationary phase. (Fig. 2). 3.1 Degradation Studies There was no interference from sample placebo; degradants peaks and calculated %Mean Assay of individual analyte from each stress condition. It showed that Caffeine; Riboflavin-5 Phosphate; Pyridoxine Hydrochloride; Nicotinamide; Thiamine HCl; and Methylparaben; Propylparaben shows 457

acceptable degradation in Oxidation condition. The Riboflavin-5 Phosphate; Nicotinamide; Thiamine HCl and Methylparaben; Propylparaben shows Significant degradation observed in Acid and base hydrolysis. The Riboflavin-5 Phosphate shows Significant degradation in all stress condition (Table 1). 3.2 Method Validation 3.2.1 System Suitability The System suitability of the method was determined by complete separation of Caffeine; Riboflavin-5 Phosphate; Pyridoxine Hydrochloride; Nicotinamide; Thiamine HCl; D- Panthenol and Methylparaben; Propylparaben from standard solution using parameters like Retention time (TR); Tailing factor (T), Theoretical plate count; Resolution (Rs); and %RSD of replicate injections was less than 4.0% from the Table 2. The results will ensure transferability of the method and increase the reliability of the results obtained. 3.2.2 Accuracy To check the degree of accuracy of the method, recovery studies were performed in triplicate by standard addition method at 80%, 100% and 120%. Known amounts of measuring analyte were added to placebo preparations and were subjected to the proposed UPLC method. Results of recovery studies are shown in Table 3. 3.23 Precision Method repeatability (intra-day precision) was evaluated by assaying six injections of sample solution. The mean % assay is well within the acceptance criterion that is; assay value should be between 97.0 and 103.0%. The intermediate precision (inter-day precision) was performed by assaying six injections of sample solution prepared by different analyst, different HPLC system in different days. The mean % assay is within the acceptance criteria. The results indicated the good precision of the developed method (Table 4). 3.2.4 Robustness To determine the robustness of the analytical method by estimating the assay of sample under deliberately modified chromatographic conditions. Deliberately modify the actual chromatographic conditions specified under the method like flow rate, solvent composition and column temperature and buffer strength on lower and higher side of the actual value. Determine the assay of analyte from Multivitamin syrup preparation under these deliberately modified chromatographic conditions. There was no significant change in the retention times of analytes and assay when the composition and flow rate of the mobile phase were changed. The results are illustrated in Table 5 through Table 6. 3.2.5 Linearity The linearity of detector response to different concentrations of all the analytes was studied in the range of 10-150 µg ml -1 at ten different levels. The results indicated good linearity. The results are given in Table 7. 3.26 Stability of analyte solutions The R.S.D. of assay of standard stock solution during solution stability and mobile phase stability experiments was within 1%. The solution stability and mobile phase stability experiments data confirms that sample solutions and mobile phase used during assay determination was stable up to 72 h. Table 1: Stress Study Results of all the analytes in multivitamin syrup preparation %Assay Robust Condition A B C D E F G H Normal 95.46 99.89 96.96 99.07 99.71 95.20 99.20 99.19 1N HCl, at 50 C for 3 days 96.90 # 90.29 99.81 98.45 100.47 # 83.10 # 89.54 # 89.88 1N NaOH, at 50 C for 3 days # 85.99 # 85.75 100.83 98.68 98.25 # 77.11 # 85.80 95.58 3%H 2O 2, at 50 C for 3 days # 87.21 # 89.64 # 71.74 99.09 # 81.62 # 86.41 101.84 98.41 at 50 C for 1 day # 82.17 # 60.05 99.52 99.80 98.90 # 89.75 101.27 98.15 Exposure to 360nm for 3 days 98.53 # 88.80 100.14 99.36 96.67 94.46 98.77 98.60 At 60 C / 75%RH for 3 days 97.02 # 87.49 100.14 98.99 97.43 103.81 99.67 99.87 * A: Nicotinamide; B: Thiamine Hydrochloride; C: Pyridoxine Hydrochloride; D: D-Panthenol; E: Caffeine anhydrous; F: Riboflavin-5 phosphate sodium; G: Methyl hydroxybenzoate; H: Propyl hydroxybenzoate # Significant degradation 458

(c) (a) (b) (d) (e) (f) (h) (g) (a) Nicotinamide (b) Pyridoxine hydrochloride (c) Panthenol (d) Thiamine hydrochloride (e) Caffeine (f) Riboflavine-5-phophate sodium (g) Methyl hydroxy benzoate (h) Propyl hydroxy benzoate Fig. 1: Chemical Structure of the Analytes 459

Fig. 2: Chromatograms showing separation of analytes at 254 nm, 200nm and 290nm Table 2: System suitability Results Name of the Peak λ-max RT K-Prime Resolution Tailing Plate count %RSD nm Min Nicotinamide 254 0.2 1.07-1.27 2149 0.04 Thiamine 254 0.3 2.21 5.51 1.31 2994 3.99 Pyridoxine 290 0.5 4.08-1.19 6791 0.19 D-Panthenol 210 1.0 8.72-1.10 20923 0.71 Caffeine 254 1.8 17.17 48.37 1.25 35802 0.05 Riboflavin- 5 -Phosphate 254 2.2 20.75 8.04 1.21 29787 0.49 Methyl hydroxy benzoate 254 3.2 30.56 30.25 1.04 757613 0.08 Propyl hydroxy benzoate 254 3.4 33.11 13.66 1.15 355450 0.23 460

Table 3: Accuracy Results Sample %Recovery level %Relative recovery ±SD 80 100.87±2.65 Nicotinamide 100 99.18±0.48 120 98.21±0.12 80 100.09±1.48 Thiamine Hydrochloride 100 98.59±0.20 120 98.59±1.52 80 96.12±1.49 Pyridoxine Hydrochloride 100 96.12±0.75 120 103.44±1.82 80 101.35±2.80 D-Panthenol 100 98.90±1.41 120 98.29±0.59 80 100.99±1.58 Caffeine anhydrous 100 99.15±0.87 120 98.54±0.18 80 94.54±1.94 Riboflavin- 5 phosphate sodium 100 94.01±0.29 120 96.07±1.37 80 99.82±2.06 Methyl hydroxybenzoate 100 99.68±1.37 120 98.60±1.26 80 96.29±8.88 Propyl hydroxybenzoate 100 96.49±7.02 120 96.80±6.57 Name of the Analyte Table 4: Precision Results Mean %Assay ± SEM* (Intraday) Mean %Assay ± SEM* (Interday) Nicotinamide 97.97+ 1.44 98.64+ 1.12 Thiamine Hydrochloride 99.65+ 0.53 99.05+ 0.43 Pyridoxine Hydrochloride 98.02+ 0.85 97.92+ 0.84 D-Panthenol 99.20+ 1.78 99.10+ 1.68 Caffeine anhydrous 97.86+ 0.83 97.88+ 0.78 Riboflavin-5 phosphate sodium 99.08+ 0.60 99.01+ 0.57 Methyl hydroxy benzoate 97.85+ 0.81 97.88+ 0.61 Propyl hydroxy benzoate 98.64+ 1.12 98.04+ 1.01 Table 5: Robustness Results for Retention time (in minutes) Retention time (min) Robust Condition A B C D E F G H Normal 0.203 0.303 0.502 1.004 1.802 2.202 3.201 3.405 Flow rate 0.99ml/min 0.206 0.306 0.506 1.011 1.808 2.208 3.202 3.402 Flow rate 1.01ml/min 0.201 0.301 0.501 0.998 1.798 2.197 3.200 3.403 Column temperature - 46ºC 0.205 0.305 0.504 1.001 1.805 2.205 3.207 3.407 Column temperature - 50ºC 0.204 0.307 0.505 1.003 1.804 2.207 3.203 3.408 0.09% TFA in water 0.202 0.306 0.506 1.008 1.809 2.209 3.205 3.402 0.11% TFA in water 0.207 0.304 0.507 1.001 1.805 2.204 3.208 3.404 % Difference Flow rate 0.99ml/min 1.48 0.99 0.80 0.70 0.33 0.27 0.03 0.09 Flow rate 1.01ml/min 0.99 0.66 0.20 0.60 0.22 0.23 0.03 0.06 Column temperature - 46ºC 0.99 0.66 0.40 0.30 0.17 0.14 0.19 0.06 Column temperature - 50ºC 0.49 1.32 0.60 0.10 0.11 0.23 0.06 0.09 0.09% TFA in water 0.49 0.99 0.80 0.40 0.39 0.32 0.12 0.09 0.11% TFA in water 1.97 0.33 1.00 0.30 0.17 0.09 0.22 0.03 * A: Nicotinamide; B: Thiamine Hydrochloride; C: Pyridoxine Hydrochloride; D: D-Panthenol; E: Caffeine anhydrous; F: Riboflavin-5 phosphate sodium; G: Methyl hydroxybenzoate; H: Propyl hydroxybenzoate 461

Table 6: Robustness Results for %assay % Assay Robust Condition A B C D E F G H Normal 97.97 99.65 98.02 99.20 97.06 99.08 97.15 98.64 Flow rate 0.99ml/min 98.11 99.11 98.43 99.43 97.13 99.12 97.88 98.22 Flow rate 1.01ml/min 98.33 99.85 98.62 99.54 97.91 99.24 97.04 98.73 Column temperature - 46ºC 97.87 99.13 98.94 99.88 97.23 99.01 97.17 98.78 Column temperature - 50ºC 98.22 99.67 98.62 99.02 97.11 99.34 97.43 98.51 0.09% TFA in water 98.17 99.22 98.67 99.04 97.24 99.53 97.88 98.11 0.11% TFA in water 98.25 99.61 98.83 99.12 97.31 99.78 97.21 98.32 % Difference Flow rate 0.99ml/min 0.14 0.54 0.42 0.23 0.07 0.04 0.75 0.43 Flow rate 1.01ml/min 0.37 0.20 0.61 0.34 0.88 0.16 0.11 0.09 Column temperature - 46ºC 0.10 0.52 0.94 0.69 0.18 0.07 0.02 0.14 Column temperature - 50ºC 0.26 0.02 0.61 0.18 0.05 0.26 0.29 0.13 0.09% TFA in water 0.20 0.43 0.66 0.16 0.19 0.45 0.75 0.54 0.11% TFA in water 0.29 0.04 0.83 0.08 0.26 0.71 0.06 0.32 * A: Nicotinamide; B: Thiamine Hydrochloride; C: Pyridoxine Hydrochloride; D: D-Panthenol; E: Caffeine anhydrous; F: Riboflavin-5 phosphate sodium; G: Methyl hydroxybenzoate; H: Propyl hydroxybenzoate Table 7: Linearity Results Name of the Analyte Slope Intercept %Y-Intercept Correlation coefficient (r 2 ) Nicotinamide 6265 501.07 0.08 0.999984 Thiamine Hydrochloride 2735-16780.94-6.36 0.997383 Pyridoxine Hydrochloride 1635 57.42 0.04 0.999975 D-Panthenol 1022 938.55 0.90 0.997832 Caffeine anhydrous 17113 1268.35 0.07 0.999986 Riboflavin-5 phosphate sodium 2100-2143.02-1.03 0.999931 Methyl hydroxyl benzoate 7529 2288.45 0.30 0.999888 Propyl hydroxyl benzoate 604-572.00-0.98 0.997029 4.0 CONCLUSION This UPLC method is accurate, precise, reproducible, specific, and stability-indicating. The method has been found to be better than previously reported methods, because of its wide range of linearity, use of an economical and readily available mobile phase, UV detection, lack of extraction procedures, low tr and no internal standard. All these factors make this method suitable for quantification of all the analytes in pharmaceutical dosage forms. The method can be successfully used for routine analysis of multivitamin preparations without interference. ACKNOWLEDGEMENTS The authors thank the management of Lee Pharma Limited; Hyderabad for providing the samples and necessary facilities for the completion of this work. REFERENCES 1. Stojanka Vidović, Biljana Stojanović, Jelena Veljković, Ljiljana Pražić-Arsić, Goran Roglić and Dragan Manojlović. Simultaneous determination of some water-soluble vitamins and preservatives in multivitamin syrup by validated stabilityindicating high-performance liquid chromatography method. Journal of Chromatography A. 2008;1202(2):155-162. 2. Staroverov VM, Deineka VI, Grigor Ev AM, Prokhoda EF, Pokrovskill MV and Ivanov VV. HPLC analysis of water-soluble vitamins in the multivitamin syrup Oligovit. Pharmaceutical chemistry journal. 2004;38(3):172-75. 3. Pavlos F. Chatzimichalakis, Victoria F. Samanidou, Robert Verpoorte and Loannis N. Papadoyannis. Development of a validated HPLC method for the determination of B-complex vitamins in pharmaceuticals and biological fluids after solid phase extraction. Journal of separation science. 2004;27(4):1181-1188. 4. Novi Yantih, Diah Widowati, Wartini and Tiwi Aryani. Validation of HPLC method for determination of thiamine hydrochloride, riboflavin, Nicotinamide, and pyridoxine hydrochloride in syrup preparation. Canadian Journal on Scientific and Industrial Research. 2011;2(7):269-78. 5. Farajzadeh MA and Nagizadeh S. A Simple and Reliable Spectrophotometric Method for the Determination of Ascorbic Acid in Pharmaceutical Preparations. Journal of Analytical Chemistry. 2003;58(10):927-932. 462

6. Mohamed A. Eldawy, Tawfik AS and Elshiabouri SR. Rapid, sensitive spectrophotometric method for the determination of ascorbic acid. Anal Chem. 1975;47(3):461-465. 7. International Conferences on Harmonization Q2 (R1), Validation of analytical Procedures: Text and methodology, 2005. 463